| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Aeva Technologies, Inc.
13D/A
AEVA · 00835Q202
|
6.5% |
7/14/2025
Event 6/16/2025
|
||||
| Canaan XI L.P. | 6.5% | |||||
| Canaan Partners XI LLC | 6.5% | |||||
| Schedule 13G · 1 security · passive | ||||||
|
Tyra Biosciences, Inc.
13G/A
TYRA · 90240B106
|
1.4% |
4/24/2026
Event 3/31/2026
|
||||
| Canaan XI L.P. | 1.4% | |||||
| Canaan Partners XI LLC | 1.4% | |||||
| Canaan 2020+ Co-Investment L.P. - Series 7 | 0% | |||||
| Canaan Partners 2020+ Co-Investment LLC | 0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.